Clinical trial
Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of…
NCT00317005 · Universidade Estadual de Londrina, Other · Completed
Key facts
| NCT number | NCT00317005 |
|---|---|
| Title | Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events |
| Official title | Randomized Clinical Trial of Folate Therapy/Placebo for Reduction of Homocysteine Serum Levels in Uremic Patients and Influence on Cardiovascular Mortality |
| Lead sponsor | Universidade Estadual de Londrina, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Uremia, Chronic Renal Failure, Hemodialysis, Hyperhomocysteinemia, Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | folate treatment |
| Enrollment | 186 |
| Start date | Apr 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Apr 21, 2006 |
| Last update posted | Jul 26, 2018 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: